Press Releases Investors Investors Overview News & Events Overview Press Releases IR Calendar Email Alerts Company Info Overview Presentations Contacts FAQ Financial Info Overview Financial Results Income Statement Balance Sheet Cash Flow Stock Data Quote Charts Historical Data SEC Filings Overview All SEC Filings Annual Reports Quarterly Reports Section 16 Filings Governance Board Committees Governance Documents News & Events Overview Press Releases IR Calendar Email Alerts Year All Years 2022 2021 2020 2019 2018 2017 2016 2015 2014 Jul 02, 2018 8:00am EDT Medovex Corporation’s DenerveX System Demonstrates Clinical Benefits in Patients Suffering from Low Back Facet Joint Pain Apr 05, 2018 9:46am EDT Medovex Corporation Announces Columbia Regulatory Approval and Issuance of Two New US Patent Approvals Feb 13, 2018 10:30am EST Medovex Corporation Presents Initial Data on the DenerveX® System During NSpine 2nd Platinum Course in Arosa, Switzerland Dec 29, 2017 4:00pm EST Medovex Corporation Converts IDE Submission to a Pre-Submission with Food and Drug Administration for its DenerveX System Nov 27, 2017 8:00am EST Medovex Corporation Submits IDE with the Food and Drug Administration for its DenerveX System Nov 21, 2017 9:00am EST Medovex Corporation to Present at the 10th Annual LD Micro Main Event Nov 20, 2017 8:00am EST Medovex Corporation Releases Letter to Shareholders Nov 15, 2017 8:00am EST Medovex Corporation Initiates Move to List on the OTCQB Market Nov 13, 2017 8:00am EST Russo Partners Teams with Medovex to Highlight Medical Technology Innovation with DenerveX System for Treatment of Chronic Back Pain Oct 27, 2017 9:54am EDT UPDATE - Medovex Corporation Comments on President Trump Declaring the Opioid Crisis a National Public Health Emergency Prev 1 2 3 4 5 6 7 8 9 10 ...14 Next
Jul 02, 2018 8:00am EDT Medovex Corporation’s DenerveX System Demonstrates Clinical Benefits in Patients Suffering from Low Back Facet Joint Pain
Apr 05, 2018 9:46am EDT Medovex Corporation Announces Columbia Regulatory Approval and Issuance of Two New US Patent Approvals
Feb 13, 2018 10:30am EST Medovex Corporation Presents Initial Data on the DenerveX® System During NSpine 2nd Platinum Course in Arosa, Switzerland
Dec 29, 2017 4:00pm EST Medovex Corporation Converts IDE Submission to a Pre-Submission with Food and Drug Administration for its DenerveX System
Nov 27, 2017 8:00am EST Medovex Corporation Submits IDE with the Food and Drug Administration for its DenerveX System
Nov 13, 2017 8:00am EST Russo Partners Teams with Medovex to Highlight Medical Technology Innovation with DenerveX System for Treatment of Chronic Back Pain
Oct 27, 2017 9:54am EDT UPDATE - Medovex Corporation Comments on President Trump Declaring the Opioid Crisis a National Public Health Emergency
